- Evonik Industries AG has already reported first quarter 2026 results of sales of €3.427 billion and net profit of €125 million, along with a pilot collaboration with Imbit to apply advanced AI at its Singapore facility.
- Although revenue slowed compared to the prior year, adjusted EBITDA was slightly above expectations, and the AI pilot aims to drive operational efficiency through real-time, model-based process insights.
- With Q1 2026 EBITDA slightly above expectations, we consider how this earnings resilience impacts Evonik’s broader investment story.
Make the most of the AI infrastructure supercycle with our top 40 “handpicks” of AI gold rushes that transform record demand into massive cash flows.
Evonik Industries investment story summary
To own Evonik today, you need to believe the company can offset the downturn in construction and autos by moving to higher-value specialty chemicals and cutting costs. Q1 2026 results, with weaker sales but slightly better-than-expected EBITDA, support our cautious view on earnings resilience, while the steep decline in share prices to date keeps dividend coverage and weak commodity exposures as key short-term risks to watch.
The AI pilot with Imbit in Singapore has the clearest link to the current revenue story, as it targets real-world production efficiency gains rather than distant promises. Scaling up this type of process optimization could strengthen Evonik’s efforts to reduce costs and improve margins at a time when demand visibility and pricing power remain uncertain. These are central to the current investment case.
However, in contrast to this apparent resilience, pressure on margins and dividend policy is something investors should be aware of if…
Read the full story about Evonik Industries (it’s free!)
Evonik Industries plans to have revenues of 14.9 billion euros and revenues of 592.7 million euros by 2029. This would require annual revenue growth of 1.9%, with revenues increasing by around €327.7 million from the current €265 million.
We reveal how Evonik Industries’ forecasts resulted in a fair value of €16.16, which is 7% lower than the current price.
explore other perspectives
Some of the lowest-ranking analysts are already cautious, assuming sales of around 15 billion euros and profits of nearly 600 million euros by 2028, and should know that they see regulatory and pricing headwinds as much more limited than the consensus view, which could weaken or strengthen over time with this Q1 report and AI pilots.
Check out 7 other fair value estimates for Evonik Industries – Why the stock could be worth 29% less than its current price!
Create your own verdict
Don’t just follow the ticker, dig deep into the data and truly build your own beliefs.
Looking for another opportunity?
The market won’t wait. These fast-moving stocks are in the spotlight right now. Get the list before running.
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
Evaluation is complex, but we will simplify it here.
Discover whether Evonik Industries is undervalued or overvalued with our in-depth analysis. Fair value estimates, potential risks, dividends, insider transactions, and financial condition.
Access free analysis
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.
